TZU-CHIAO LU to Carcinoma, Intraductal, Noninfiltrating
This is a "connection" page, showing publications TZU-CHIAO LU has written about Carcinoma, Intraductal, Noninfiltrating.
Connection Strength
0.390
-
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). BMC Cancer. 2023 Sep 14; 23(1):865.
Score: 0.199
-
High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study. World J Surg Oncol. 2023 Feb 17; 21(1):48.
Score: 0.191